TRANSPLANTATION PROCEEDINGS, vol.47, no.5, pp.1528-1530, 2015 (SCI-Expanded)
Background. New-onset diabetes after transplantation (NODAT) is a common metabolic complication. Most conventional immunosuppressive medications, especially steroids and tacrolimus, are responsible for its development. NODAT may rarely be associated with severe, life-threating complications in kidney transplantation recipients.